Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $10.2100 (-1.35%) ($10.0500 - $10.4500) on Tue. Mar. 19, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.11% (three month average) | RSI | 46 | Latest Price | $10.2100(-1.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.4% a day on average for past five trading days. | Weekly Trend | IOVA declines -2.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(48%) ARKG(47%) IWO(43%) ARKK(41%) | Factors Impacting IOVA price | IOVA will decline at least -2.055% in a week (0% probabilities). VXX(-13%) VIXM(-8%) UUP(-7%) IFRA(-4%) TLT(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.055% (StdDev 4.11%) | Hourly BBV | 0 () | Intraday Trend | -2% | | | |
|
Resistance Level | $10.32 | 5 Day Moving Average | $10.19(0.2%) | 10 Day Moving Average | $10.19(0.2%) | 20 Day Moving Average | $10.32(-1.07%) | To recent high | -9.3% | To recent low | 36% | Market Cap | $1.495b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |